Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70β

American Journal of Pathology

Volumn 172, Issue 1, 2008, Pages 225-235

  Peng, Yi ^a   Li, Caihong X ^a   Chen, Fei ^a   Wang, Zhengxin ^d   Ligr, Martin ^a   Melamed, Jonathan ^a   Wei, Jianjun ^a   Gerald, William ^c   Pagano, Michele ^a   Garabedian, Michael J ^a   Lee, Peng ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARA70 GENE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; GENE; GENE INTERACTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 38749137737     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070065     Document Type: Article

References (38)

1. Taplin ME, Balk SP: Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004, 91:483-490
2. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, Trapman J: Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999, 69:307-313
3. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW: Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 1999, 69:3-12
4. Kumar R, Wang RA, Barnes CJ: Coregulators and chromatin remodeling in transcriptional control. Mol Carcinog 2004, 41:221-230
5. Janne OA, Moilanen AM, Poukka H, Rouleau N, Karvonen U, Kotaja N, Hakli M, Palvimo JJ: Androgen-receptor-interacting nuclear proteins. Biochem Soc Trans 2000, 28:401-405
6. Gelmann EP: Molecular biology of the androgen receptor. J Clin Oncol 2002, 20:3001-3015
7. Heinlein CA, Chang C: Androgen receptor (AR) coregulators: an overview. Endocr Rev 2002, 23:175-200
8. Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z: Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol 2002, 161:1467-1474
9. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C: Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 2000, 6:1891-1895
10. Ueda T, Bruchovsky N, Sadar MD: Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 2002, 277:7076-7085
11. Müller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R, Schule R: The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 2002, 21:736-748
12. Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK: ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 2004, 279:13944-13952
13. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A: Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994, 9:509-516
14. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA: Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994, 54:2979-2985
15. Yeh S, Chang C: Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996, 93:5517-5521
16. He B, Minges JT, Lee LW, Wilson EM: The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J Biol Chem 2002, 277:10226-10235
17. Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. J Biol Chem 2004, 279:33438-33446
18. Gao T, Brantley K, Bolu E, McPhaul MJ: RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. Mol Endocrinol 1999, 13:1645-1656
19. Zhou ZX, He B, Hall SH, Wilson EM, French FS: Domain interactions between coregulator ARA70 and the androgen receptor (AR). Mol Endocrinol 2002, 16:287-300
20. Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B: Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 1999, 13:117-128
21. Tekur S, Lau KM, Long J, Burnstein K, Ho SM: Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids. Mol Carcinog 2001, 30:1-13
22. Kollara A, Kahn HJ, Marks A, Brown TJ: Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat 2001, 67:245-253
23. Peng Y, Chiriboga L, Pei Z, Wang Z, Lee P: Androgen receptor coactivator ARA70α and ARA70β isoform-specific antibodies: new tools for studies of expression and immunohistochemical localization. Appl Immunohistochem Mol Morphol, [Epub ahead of press]
24. Sherman F: Getting started with yeast. Methods Enzymol 1991, 194:3-21
25. Gietz RD, Schiestl RH, Willems AR, Woods RA: Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 1995, 11:355-360
26. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A: Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res 1993, 53:1304-1311
27. Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP, Brown TJ: Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 1997, 126:59-73
28. Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K: Prostate stromal cellderived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate 1999, 41:145-153
29. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264
30. Osman I, Sorhaindo L, Navarro D, Taneja S, Lee P, Christos P, Shen R, Nanus D: Loss of neutral endopeptidase and Akt activation is associated with prostate cancer progression. Cancer 2006, 107:2628-2636
31. Abdulkadir SA: Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann NY Acad Sci 2005, 1059:33-40
32. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP: Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 2005, 65:1164-1173
33. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT, Nanus DM: Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res 2001, 7:1370-1377
34. Gallee MP, Visser-de Jong E, van der Korput JA, van der Kwast TH, ten Kate FJ, Schroeder FH, Trapman J: Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Urol Res 1990, 18:181-187
35. Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A, Balaji KC: Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 2005, 23:402-406
36. Paul R, Ewing CM, Jarrard DF, Isaacs WB: The cadherin cell-cell adhesion pathway in prostate cancer progression. Br J Urol 1997, 79(Suppl 1):37-43
37. Gu Y, Li H, Miki J, Kim KH, Furusato B, Sesterhenn IA, Chu WS, McLeod DG, Srivastava S, Ewing CM, Isaacs WB, Rhim JS: Phenotypic characterization of telomerase-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines. Exp Cell Res 2006, 312:831-843
38. Whitacre DC, Chauhan S, Davis T, Gordon D, Cress AE, Miesfeld RL: Androgen induction of in vitro prostate cell differentiation. Cell Growth Differ 2002, 13:1-11